Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2022 | How COVID-19 has impacted clinical practice and treatment approaches in multiple myeloma

Meera Mohan, MD, MS, FACP, Medical college of Wisconsin, Milwaukee, WI, briefly discusses how COVID-19 has impacted treatment approaches and clinical practice in multiple myeloma (MM). In general, the approach to treatment has changed, with more virtual visits taking place. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

GSK: Research Funding; BMS/Celgene: Research Funding; Takeda: Research Funding; Novartis: Research Funding.